Engineers from the University of Hong Kong have developed a generative AI-based imaging method that supports cancer diagnosis.
HOW IT WORKS
CytoMAD (Cyto-Morphology Adversarial Distillation) combines AI and microfluidic technology to do label-free imaging of tumours at the individual cell level. It can capture cell images "at great speed, enhance these images, and automatically correct...
King's College London and global pharmaceutical company, GlaxoSmithKline (GSK), have formed a new five-year partnership to use AI to provide insight into why and how some patients respond to certain cancer treatments.
WHY IT MATTERS
The collaboration will use AI systems to build tools that will support clinical decision-making to help improve patient outcomes.
This move has resulted in the...
Merck KGaA, Darmstadt, and Silicon Valley-area big data company Palantir Technologies announced a joint venture that will focus on building an analytics and collaborative technology platform for cancer researchers.
Called Syntropy, the Boston-based effort will rely on Palantir Foundry to power its data integration platform. Any research data shared across participating groups will be transparent...
.jpeg?itok=UZpRIE7y "The partnership aims to investigate the role genetics play in developing personalised cancer treatments.")
